MEDIASSIST NSI Week ended 07 Aug 2026

Weekly Investor Report

MEDI ASSIST HEALTH SER L · Healthcare · Healthcare Plans

Open interactive chart View report data
Latest close 365.0 INR
1.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 0.1% above the Trend Line and sits at 23.9% of its 52-week range. The latest completed week returned 1.9%, after a 2.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100.

Setup score 31 out of 100
Latest Close 365.0 INR 7 Aug 2026
1W Return 1.9% latest completed week
4W Return 2.0% short-term follow-through
12W Return -5.2% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.9% Latest completed week; four-week move 2.0%. Indicator stack 14/49 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 56/100 25 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 0.1% above the Trend Line and sits at 23.9% of its 52-week range. The latest completed week returned 1.9%, after a 2.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0812-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.0% over four weeks, -5.2% over 12 weeks, and -32.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.9%
4W2.0%
12W-5.2%
26W-9.6%
52W-32.5%
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.22Latest activity-pressure read.
Pressure change-66.1%Four-week change in activity pressure.
Leadership-12.64Latest relative-leadership reading.
RS change19.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value40/100Relative valuation strength. Underlying universe rank 61; rank 1 is best.
Quality82/100Profitability and accounting quality. Underlying universe rank 19; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework56/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
31.0x
Price divided by trailing earnings.
Price / sales
3.0x
Market value relative to trailing revenue.
EV / EBITDA
15.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
56.4%
Gross profit retained from each unit of revenue.
Operating margin
10.8%
Operating profit retained from revenue.
Free-cash-flow margin
6.9%
Free cash flow generated from revenue.
Return on invested capital
8.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
25.1%
Latest one-year revenue growth.
EPS growth
-8.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-32.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-7.5%
Net share repurchases relative to market value.
Shareholder yield
-7.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 25 relevant articles.

8 positive · 16 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.6%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+10.9%Week of 10 Apr.
Worst week-12.8%Week of 6 Mar.
Latest week+1.9%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses7
Sharp losses7
Recent vol3.2%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryIN Healthcare Plans
4-week rank1 / 1
Group average2.0%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership

Four-week leaders

MEDIASSIST · NSI2.0%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.08; No reversal markers Factors40/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 92; Small Cap Core rank 71 SVQF56/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 696.5 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 25 relevant articles.

Medi Assist Healthcare Services’ Q4 PAT jumps 51%, operating revenue rises 23% Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026365.0 INR1.9%364.6 INR490.6 INR0.22-12.64569.8KOff
31 Jul 2026358.0 INR5.3%366.9 INR491.5 INR0.24-14.35660.6KOff
24 Jul 2026340.0 INR-4.6%370.5 INR492.6 INR0.35-17.16637.6KOff
17 Jul 2026356.5 INR-0.4%374.1 INR493.7 INR0.53-15.85301.8KOff
10 Jul 2026357.8 INR-4.5%376.7 INR494.8 INR0.65-15.77609.3KOff
3 Jul 2026374.7 INR3.2%380.5 INR495.9 INR0.66-12.77499.4KOff
26 Jun 2026363.1 INR-0.3%383.6 INR496.8 INR0.55-15.180Off
19 Jun 2026364.4 INR-2.3%387.4 INR497.9 INR0.54-15.1654.7KOff
12 Jun 2026373.0 INR4.4%390.6 INR498.9 INR0.64-12.05572.6KOff
5 Jun 2026357.2 INR-3.1%393.3 INR500.0 INR0.71-15.2170.6KOff
29 May 2026368.6 INR-0.9%397.8 INR501.1 INR0.79-13.61581.0KOff
22 May 2026371.9 INR-3.4%404.5 INR502.2 INR0.71-13.881.4MOff
15 May 2026384.8 INR2.1%410.2 INR503.3 INR0.42-11.001.2MOff
8 May 2026376.8 INR9.2%415.8 INR504.3 INR0.10-14.99855.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context